Clinical Trials Logo

Celiac Disease in Children clinical trials

View clinical trials related to Celiac Disease in Children.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06038344 Active, not recruiting - Clinical trials for Adherence, Treatment

Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease

Start date: June 22, 2021
Phase: N/A
Study type: Interventional

Celiac disease (CD) is an autoimmune gastrointestinal disease that is caused by intolerance to gluten in the diet. The mainstay of treatment is a gluten-free diet (GFD). Children with CD on the GFD often have low micronutrient intakes (e.g. folate, iron) and high intakes of sugar and fat. Current Canadian nutrition guideline does not address these nutritional limitations. The investigation team developed a novel GF-food guide (GFFG). This randomized clinical trial aims to evaluate the impact of GFFG on diet quality and adherence to the GFD in newly diagnosed children and youth with celiac disease in the clinical setting. The investigators will compare dietary counselling using the GFFG versus the standard of care in children newly diagnosed with CD and their parents to see if participant care outcomes (diet quality, nutrition literacy, adherence to the GFD) improved over six months.

NCT ID: NCT05548166 Active, not recruiting - Celiac Disease Clinical Trials

Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease

Start date: October 26, 2020
Phase:
Study type: Observational

A multicentre, prospective observational study to develop the CELIAC-Q KIDS patient reported outcome measure for children and adolescents with celiac disease. The CELIAC- Q KIDS will contain a comprehensive set of independently functioning scales designed to measure outcomes that matter to children with celiac disease, as well as scales to measure patients experience with the gluten-free diet.

NCT ID: NCT05442398 Active, not recruiting - Clinical trials for Celiac Disease in Children

Celiac Disease and Diabetes Mellitus

Start date: July 1, 2022
Phase:
Study type: Observational [Patient Registry]

The aim of the present study is to detect Celiac Disease among suspected patients with Type 1 Diabetes Mellitus who admitted to Assiut University Children's Hospital during one year duration

NCT ID: NCT04593888 Active, not recruiting - Autoimmune Diseases Clinical Trials

Gluten Reduction and Risk of Celiac Disease

GRAIN
Start date: May 5, 2021
Phase: N/A
Study type: Interventional

Celiac disease shares many features of other autoimmune diseases such as type 1 diabetes. Recently, it was published that higher amounts of gluten intake increased the risk for celiac disease. Optimal amounts of gluten to be introduced during weaning have not yet been established. The aim is to investigate if a gluten-restricted diet (e.g. below 3 gram per day) during the first 3 years of life will reduce the risk of develop CDA and IA in genetically predisposed children by the age of 7 years. Children who screened positive for HLA DQ2/X (X is neither DQ2 nor DQ8) in the GPPAD-02 (ASTR1D [ClinicalTrials.gov Identifier NCT03316261]) screening will be contacted by a study nurse.